Skip Page Header

Home > Gamma Hydroxybutyrate & Gamma Butrolactone (GHB/GBL): a case series of inpatient & outpatient detoxification.

Santlal, Kiran and Gibbons, Zorina and McCarron, Peter and Keenan, Eamon (2017) Gamma Hydroxybutyrate & Gamma Butrolactone (GHB/GBL): a case series of inpatient & outpatient detoxification. In: Club Health Dublin, 24-26 June 2017, Dublin.

[img]
Preview
PDF (Gamma Hydroxybutyrate & Gamma Butrolactone (GHB/GBL): a case series of inpatient & outpatient detoxification)
3MB

GHB is a natural endogenous neurotransmitter. It can also be ingested orally and crosses the blood-brain barrier. It is structurally similar to gamma-aminobutyric acid (GABA) and acts on GABA & GHB receptors in brain with effects on the dopaminergic system. It is rapidly eliminated and not detectable after: 4 hours in the blood 12 hours in the urine.

This poster includes: Symptoms of GHB overdose and withdrawal, Management of GHB overdose and withdrawal, Treatment episodes & outcomes in the GHB clinic.


Repository Staff Only: item control page